I saw that, igoe. Those videos are interesting to get some alternative views from various fund managers. I'd like to hear Christopher Mills take on it again. Spire was his favourite share for 2025 with his expectations, if I recall, being that earnings would grow substantially and debt would reduce significantly over the next couple of years. He also noted the property valuation point that Paul Hill pointed out and that there may be external interest from India to take over the business. I haven't studied the results in details but I'd be interested to dig into the debt and earnings figures to see if Christopher's view on these appear to stack up. |
I see paul Hill from vox markets has taken up a position in SPI, he mentioned the assets are worth a hell of alot more than the current shareprice... |
Took a small position at 1.69. The drop certainly seems to be overdone. |
RSI down to 10! |
JPMorgan cuts Spire Healthcare price target to 309 (321) pence - 'overweight'very modest TP reduction post update. market reaction on other hand has been brutal. |
happy to add at these levels |
Directors buying.
10p-11p EPS more likely so 17x P/E. Lowest in years. |
No chance 14p earnings |
 Spire Healthcare’s profit to be hit by £30m costs increase
Shares in private healthcare provider fall sharply as looming national insurance rise and higher energy prices take toll
Rising employment and energy costs as well as a shift from self-pay to private insurance is set to hit profits at Spire Healthcare by about £30m this year, triggering a sell-off in its shares. Alongside mixed full-year results on Thursday, the FTSE 250 private healthcare company forecast adjusted profits of between £270m and £285m this year, below the City’s forecasts. Spire said this was because of a combination of April’s rise in employers’ national insurance contributions, the national minimum wage, “payor mix changes” and increased energy costs.
The FTSE 250 company said that it expected to offset about £10m of these costs this year, including by accelerating cost savings and self-pay price changes. An efficiency programme, announced two years ago, including digitising administration, is “delivering ahead of plan” and will be sped-up. Spire therefore expects savings of at least £30m this year, about £10m above its initial plans. It has also expanded its 2024 to 2026 cumulative savings target to £80m, from £60m. But with its profit outlook for this year below the consensus forecast of analysts, shares in Spire were down 16%, or 36p, to close at 188½p on the London Stock Exchange. Despite today’s share declines, the stock is up about 70% over the past five years, although it remains below the 250p takeover offer from Ramsay Health Care, an Australian competitor, in 2021 which, unusually, was voted down by shareholders.
Complete article: |
£1.4 billion of freehold property, this is more like a property fund, there spending £100 million a year on capex too, basically at this share price the whole business is valued at zero..... that's just a crazy valuation |
Deutsche Bank Research cuts Spire Healthcare target to 300 (320) pence - 'buy' |
The commies are doing their best |
Operating profit and EBITDA are still expected to rise this year, despite the extra costs. |
Another great success for Reeves' budget policies.
Company after company are having to lower their forecasts as a result, Spire is far from being alone.
Prices will have to rise to cover these increased costs across the board, inflation will rise and interest rate cuts will slow down or halt. Great work Reeves and co.! |
I feel sick ! |
Some clueless posters on here unfortunately.
Some of us were around when the stupid board rejected a bid of 300p by Mediclinic 6-7 years ago and then by Ramsay of 250p in 2021-22.
The EPS and P/E ratios above are incorrect.
DYOR. |
From Morningstar, not sure if it's been updated. P/E ratio still too high. Combined with NI and Tax increases, this could fall further.
Dividend yield 0.94%Market capitalisation £745.33 mnP/E ratio 33.01 |
Stocko red |
IC have a buy. |
The share price is covered by the land and property alone, so your basically getting the business for free, that's what it looks like in the accounts and that's why its touted as a bid target, the NI increases were known costs before today, so surely today is just a massive over reaction, if there's potential bidders out there now seems like a good time to pounce! |
New 4 year low. This share was recommended as his best stock idea of 2025 by Christopher Mills, talking to Paul Hill circa 7 weeks ago when the shareprice was 237p. Just goes to show that nobody has infallible wisdom where the stock market is concerned even when they have a much closer insight into the business than is possible for any external investors.
"I don't frankly see a lot of downside on this because we know that the business is performing well. We know that the demand is sitting there and the dividend is going to go up a lot and the share is going to go up a lot. I kinda see it as a one way bet really." Christopher Mills of Harwood Capital, 15 January. |
Bid deffo I think! |
Been following, disappointing rns. |
Another interesting development directly from the effect of NCI is the number of businesses closing for lunch. The effect in employment falling is going to off set the increase and result in higher demands on welfare which chief fu officer is also clamping down on |
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
